Julia Tobacyk

Researcher

UAMS

Last publication 2024 Last refreshed 2026-05-16

faculty

7 h-index 21 pubs 185 cited

Research Areas

Links

ORCID Lab Website

OverviewAI-generated summary

Julia Tobacyk's research focuses on understanding the physiological and behavioral effects of various substances and environmental factors in animal models. Her work has investigated the impact of early life adversity on ethanol self-administration and adrenergic receptor expression in adolescent rats, as well as the effects of limited bedding and nesting on ethanol consumption in female rats. Tobacyk has also explored the interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome and the protective effects of deuterated buprenorphine in pregnant rats. Additionally, her research includes studies on mitochondrial injury in rat renal proximal tubular cells, examining the role of MnSOD and OMA1-dependent OPA1 proteolytic processing. She has also analyzed public discourse related to FDA inquiries on kratom. Tobacyk collaborates with researchers at the University of Arkansas for Medical Sciences, including Lisa K. Brents, Brian J. Parks, and Michael D. Berquist.

Metrics

h-index: 7
Publications: 21
Citations: 185

Selected Publications

Deuterated Buprenorphine Mitigates Fentanyl Effects in Pregnant Rats (2024)

DOI OpenAlex
Limited bedding and nesting increases ethanol drinking in female rats (2024)

8 citations DOI OpenAlex
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023)

2 citations DOI OpenAlex
Effects of a two-hit model of early life adversity on oral ethanol self-administration and adrenergic receptor expression in adolescent rats (2023)

DOI OpenAlex
481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023)

DOI OpenAlex
Response to article – alternative interpretation of “there is reduced immunohistochemical staining of placental aromatase in severe neonatal opioid withdrawal syndrome” (2023)

DOI OpenAlex
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome. (2022)

DOI OpenAlex
Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom (2022)

14 citations DOI OpenAlex
Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception (2022)

DOI OpenAlex
384 Motives for kratom self-medication: contents of public comments solicited by the FDA (2022)

1 citation DOI OpenAlex
Overexpression of MnSOD Protects against Cold Storage-Induced Mitochondrial Injury but Not against OMA1-Dependent OPA1 Proteolytic Processing in Rat Renal Proximal Tubular Cells (2021)

1 citation DOI OpenAlex
Fluorescence-Based Assay For Measuring OMA1 Activity (2021)

3 citations DOI OpenAlex